List of Excipients in API POMALIDOMIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing POMALIDOMIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Celgene Corporation | POMALYST | pomalidomide | 59572-501 | MANNITOL | |
| Celgene Corporation | POMALYST | pomalidomide | 59572-501 | SODIUM STEARYL FUMARATE | |
| Celgene Corporation | POMALYST | pomalidomide | 59572-501 | STARCH, CORN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing POMALIDOMIDE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 | ALCOHOL |
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 | AMMONIA |
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 | BUTYL ALCOHOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for POMALIDOMIDE
Excipient focus: ALCOHOL
POMALIDOMIDE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
POMALIDOMIDE drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
POMALIDOMIDE drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
POMALIDOMIDE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
POMALIDOMIDE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
POMALIDOMIDE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
POMALIDOMIDE drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
POMALIDOMIDE drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
POMALIDOMIDE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
POMALIDOMIDE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| Celgene Corporation | pomalidomide | 59572-501 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
POMALIDOMIDE drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
POMALIDOMIDE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
POMALIDOMIDE drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
POMALIDOMIDE drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| Celgene Corporation | pomalidomide | 59572-501 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
POMALIDOMIDE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| Celgene Corporation | pomalidomide | 59572-501 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
POMALIDOMIDE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
POMALIDOMIDE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | pomalidomide | 51991-342 |
| >Company | >Ingredient | >NDC |
POMALIDOMIDE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | pomalidomide | 59572-501 |
| Natco Pharma Limited | pomalidomide | 63850-0131 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
